Search
for
Sort by
Research 301–330 of 1000+
- Erosive pustular dermatosis of the scalp: a multicentre study
- Generalized pustular psoriasis responsive to PUVA and oral cyclosporin therapy
- Platycarya strobilacea S. et Z. Extract Has a High Antioxidant Capacity and Exhibits Hair Growth-promoting Effects in Male C57BL/6 Mice
- Effective high-throughput isolation of enriched platelets and circulating pro-angiogenic cells to accelerate skin-wound healing
- Skin Diseases in Horses
- Therapeutic Application of Microsponges-based Drug Delivery Systems
- Adverse effects of platelet-rich plasma and microneedling
- <i>Althaea officinalis</i> improves wound healing in rats: a stereological study
- Hypothyroidism in a Dog-A Case Report
- Role of neurosteroids in ischemic postconditioning-induced attenuation of cerebral ischemia-evoked neuronal injury and behavioral deficits in mice
- CME examination for volume 43
- Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report
- Study the correlation between Helicobacter pylori and insulin resistance in a group of women with polycystic ovarian syndrome in Baghdad city
- Hidradenitis suppurativa: a new therapeutic approach for an old disease
- 7 Microneedling and Platelet-Rich Plasma
- Acitretin for the Treatment of Psoriasis: A Case Report of Long-Lasting Alopecia
- Platelet-Rich Plasma in Cosmetic Surgery
- The Role of Hair Restoration Surgery in Primary Cicatricial Alopecia
- Successful Management of Folliculitis Decalvans
- NEW YORK DERMATOLOGICAL SOCIETY
- DEMODICOSIS WITH TICKS INFESTATION AND BABESIOSIS IN A MIXED DOG
- The eyelash comes to the fore
- Severe cutaneous adverse reactions to drugs
- Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
- Animal models for the study of fetal tissue repair
- Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Reversible Alopecia Universalis During Treatment with PEG-Interferon and Ribavirin for Chronic Hepatitis C
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Controlled Release of the α-Tocopherol-Derived Metabolite α-13′-Carboxychromanol from Bacterial Nanocellulose Wound Cover Improves Wound Healing